Inhibition of telomerase enhances apoptosis induced by sodium butyrate via mitochondrial pathway

Apoptosis

Volumn 11, Issue 5, 2006, Pages 789-798

  Xi, L ^a   Chen, G ^a   Zhou, J ^a   Xu, G ^a   Wang, S ^a   Wu, P ^a   Zhu, T ^a   Zhang, A ^a   Yang, W ^a   Xu, Q ^a   Lu, Y ^a   Ma, D ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

AIF; Apoptosis; Cytochrome c; HTERT; Telomerase; Telomere

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; ANTINEOPLASTIC AGENT; BUTYRIC ACID; CISPLATIN; CYTOCHROME C; DOCETAXEL; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENIC ACTIVITY; CELL PROLIFERATION; CHEMOSENSITIVITY; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; TELOMERE; UTERINE CERVIX CANCER; WILD TYPE;

ANIMALS; APOPTOSIS; BUTYRIC ACID; CISPLATIN; CYTOCHROMES C; DRUG ADMINISTRATION SCHEDULE; HELA CELLS; HUMANS; MICE; MICE, NUDE; MITOCHONDRIA; TAXOIDS; TELOMERASE; TELOMERE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 33745016300     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-006-5701-2     Document Type: Article

References (41)

1. Harley C. Telomere loss:mitotic clock or genetic time bomb? Mutation Res 1991; 256: 271-282.
2. Griffith JD, Comeau L, Rosenfield S, et al. Mammalian telomeres end in a large duplex loop. Cell 1999; 97: 503-509.
3. Greider CW. Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA 1998; 95: 90-92.
4. Greaves M. Is telomerase activity in cancer due to selection of stem cells and differentiation arrest? Trends Genet 1996; 12: 127-128.
5. Masutomi K, Yu EY, Khurts S, et al. Telomerase maintains telomere structure in normal human cells. Cell 2003; 114: 241-253.
6. Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is up regulated in tumor cells and immortalization. Cell 1997; 90: 785-795.
7. Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277: 955-959.
8. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279: 349-352.
9. Morales CP, Holt SE, Ouellette M, et al. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet 1999; 21: 111-114.
10. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998; 396: 84-88.
11. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Creation of human tumour cells with defined genetic elements. Nature 1999; 400: 464-468.
12. Kraemer K, Fuessel S, Schmidt U, et al. Antisense-mediatd hTERT inhibition specifically reduces the growth of human Bladder cancer cells. Clin Cancer Res 2003; 9: 3794-3800.
13. Teng L, Specht M, Barden C, Fahey T. Antisense hTERT inhibits thyroid cancer growth. Clin Endo Meta 2003; 88: 1362-1366.
14. Kosciolek BA, Kalantidis K, Tabler M, Rowley PT. Inhibition of telomerase activity in human cancer cells by RNA interference. Mol. Cancer Ther 2003; 2: 209-216.
15. Folini M, Pennati M, Zaffaroni N. Targeting human telomerase by antisense oligonucleotides and ribozymes. Curr Med Chem-Anti-Cancer Agents 2002; 2: 605-612.
16. Zhang XL, Mar V, Zhou W, Harrington L, Robinson MO. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev 1999; 13: 2388-2399.
17. Hahn WC, Stewart SA, Brooks MW, et al. Inhibition of telomerase limits the growth of human cancer cells. Nat Med 1999; 5: 1164-1170.
18. Misawa M, Tauchi T, Sashida G, et al. Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells. Int J Oncol 2002; 21: 1087-1092.
19. Zhang Y, Cao EH, Liang XQ, Qin JF. Increasing sensitivity to arsenic trioxide-induced apoptosis by altered telomere state. Eur J Pharmacol 2003; 474: 141-147.
20. Kondo Y, Kondo S, Tanaka Y, Haqqi T, Barna BP, Cowell JK. Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis. Oncogene 1998; 16: 2243-2248.
21. Zhang P, Chan S, Fu W, Mendoza M, Mattson M. TERT suppresses apoptotis at a premitochondrial step by a mechanism requiring reverse transcriptase activity and 14-3-3 protein binding ability. FASEB J 2003; 17: 767-769.
22. Pandita T, Joseph L. Role of telomerase in radiocurability (Review). Oncology Reports 2003; 10: 263-270.
23. Kim R. Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 2005; 103: 1551-1560.
24. Ghobrial IM, Witzig TE, Adjei AA. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 2005; 55: 178-194.
25. Bandyopadhyay D, Mishra A, Medrano EE. Overexpression of histone deacetylase 1 confers resistance to sodium butyrate-mediated apoptosis in melanoma cells through a p53-mediated pathway. Cancer Res 2004; 64: 7706-7710.
26. Liu CA, Wang MJ, Chi CW, Wu CW, Chen JY. Rho/Rhotekin-mediated NF-kappaB activation confers resistance to apoptosis. Oncogene 2004; 23: 8731-8742.
27. Emanuele S, D'Anneo A, Bellavia G, et al. Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria/caspase pathway, associated with degradation of beta-catenin, pRb and Bcl-XL. Eur. J Cancer 2004; 40: 1441-1452.
28. Xi L, Wu MF, Feng YD, et al. Seletive apoptosis in HeLa cells induced by sodium butyrate and its mechanism. ACTA Academiae Medicine Science 2003; 25: 401-405.
29. Xi L, Wu MF, Wu JH, et al. Telomerase inhibition during apoptosis induced by sodium butyrate. Zhonghua Zhongliu Za Zhi 2005; 27: 9-12.
30. Gallego MA, Joseph B, Hemstrom TH, et al. Apoptosis-inducing factor determines the chemoresistance of non-small-cell lung carcinomas. Oncogene 2004; 23: 6282-6291.
31. Lee K, Rudolph L, Ju Y, et al. Telomere dysfunction alters the chemotherapeutic profile of transformed cells. Proc Natl Acad Sci USA 2001; 98: 3381-3386.
32. Ramirez R, Carracedo J, Jimenez R, et al. Massive telomere loss is an early event of DNA Damage-induced apoptosis. J Biol Chem 2003; 278: 836-842.
33. Jarboe EA, Liaw KL, Thompson LC, et al. Analysis of telomerase as a diagnostic biomarker of cervical dysplasia and carcinoma. Oncogene 2002; 21: 664-673.
34. Takakura M, Kyo S, Kanaya T, Tanaka M, Inoue M. Expression of human telomerase subunits and correlation with telomerase activity in cervix cancer. Cancer Res 1998; 58: 1558-1561.
35. Snijders PJ, van Duin M, Walboomers JM, et al. Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial Neoplasia Grade lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA. Cancer Res 1998; 58: 3812-3818.
36. Wisman G, Knol A, Helder M, Krans M, et al. Telomerase in relation to clinicopathologic prognostic factors and survival in cervix cancer. Int J Cancer 2001; 91: 658-664.
37. Shin KH, Kang MK, Dicterow E, Kameta A, Baluda MA, Park NH. Introduction of human telomerase reverse transcriptase to normal human fibroblasts enhances DNA repair capacity. Clin Cancer Res 2004; 10: 2551-2560.
38. Louis M, Rosato RR, Brault L, et al. The histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stress. Int J Oncol 2004; 25: 1701-1711.
39. Dawson VL, Dawson TM. Deadly Conversations: Nuclear-Mitochondrial Cross-Talk. J Bioenerg Biomembr 2004; 36: 287-294.
40. Corbiere C, Liagre B, Terro F, Beneytout JL. Induction of antiproliferative effect by diosgenin through activation of p53, release of apoptosis-inducing factor (AIF) and modulation of caspase-3 activity in different human cancer cells. Cell Res 2004; 14: 188-196.
41. Diaz GD, Li Q, Dashwood RH. Caspase-8 and apoptosis-inducing factor mediate a cytochrome c-independent pathway of apoptosis in human colon cancer cells induced by the dietary phytochemical chlorophyllin. Cancer Res 2003; 63: 1254-1261.